Monte379, great summary. I agree with most everything you stated.
I began following CELZ perhaps a little later than you but around May of 2018. I read lot of anticipatory opinions of Due Diligence from a lot of folks attempting to calculate the future revenues that didn’t seem that plausible but I invested in the company and the potential that I saw in CELZ, not in other folks exuberant DD or their projections of revenue in such a short period of time.
Knowing that this is a startup company I understood that it would take quite a long time from a Convention they were going to attend to the actual commercialization of their products. I saw investors coming in with breakneck speed and raising the pps in an odd fashion because the product was too new and really CELZ was not bringing in the revenue to support such a rise in PPS that appeared impulsive. At that period, around or just under one cent was my thought at the time because the proposed commercialization of CELZ really hadn’t begun in earnest but held a lot of promise. CELZ is still ,in my mind, with CaverStem, FemCelz and now StemSpine and other procedures building upon other patents holding a lot of promise for the future, not now, but hopefully within a few years.
The last company they started “Medistem” appeared to be a success and rewarded shareholders very well. In one email to CELZ that was answered, the company did NOT express concern with the pps as it fell from .07 to .03 and was not prepared to speak about the granularity of the pps. However we now see as the pps evaporated an anticipated r/s situation where CELZ will supposedly attempt to bring that pps to one cent. We’ll have to see if that happens.
CELZ has a product and technology, patents and research making this portion of CELZ a pretty good investment. I still see CELZ’s technology as a great thing, but the realistic timeline has had bumps in the road and the outlook for other countries performing the procedures, aside from the US and Italy, like Russia has withered. I wish CELZ would give investors updated information about other countries prospect. CELZ clinical trials appeared to come at glacial speed for many, but that’s how these trials play out. They’re not all alike, some are quicker than others, but CELZ clinical trials now have some published results showing a safe and effective treatment.
CELZ’s continued financing with toxic notes is totally unfortunate to say the least. I do wonder if this proposed 150:1 r/s will take place. My guess is yes but I guess we’ll have to wait and see.
I still do not see CELZ as a scam or fraud, but anybody can opine otherwise unendingly as that is their prerogative. Others can continue pointing out to either stock or financing as lies and show us website captures and whatever and on an on, but CELZ has never been investigated for fraud or corruption by any regulatory authority thus I just don’t believe all that B.S. Yelling B.S. a million times simply does not make it so. All the diversionary B.S. about CELZ is just that, nothing but diversion and more of an illusion. Future investors should take all that B.S. into account. I'm not talking about the pps, that's a different story.
CELZ continues to show promising technology for the future and that’s still uncharted territory. I’m in this for the technology, patents and kits that are eventually bought. The more the better. Obviously, I wish for more kits to be sold for more procedures performed and more doctors trained. Maybe with the clinical trials published, CELZ can move forward in that direction.
